Medical Devices
BEPI revolutionizes hospital therapy with an automated drug dispenser at the patient's bedside, eliminating errors, delays and complications
Team with more than 20 years of experience in health care, technology and management
The market for automated pill dispensers will reach $6.3 billion by 2032, with a CAGR of 8.4 percent
Recurring revenue model based on the association between dispenser and patient via an ID bracelet
2 patent applications for industrial invention and utility model with favorable UIBM opinion
TAX Bonus
Innov STARTUP
SIM
LP
Target + SPV
The genesis of BEPI was inspired by the need to address deficiencies in the Italian nursing system by identifying an automated solution to improve efficiency in drug administration. The project was born from the vision of Marco Scardino, head of anesthesia, supported by an experienced team eager to introduce innovations in healthcare. According to recent studies[1], about one in four patients suffers an adverse event during their hospitalization, and almost half of these are due to errors in drug administration. In Italy, in 2023, out of more than 7 million hospitalizations, an estimated 700,000 potentially preventable errors occurred. In an ideal system, one nurse cares for 6 patients; unfortunately, severe staffing shortages often lead to managing more than twice as many, which generates delays, errors, and complications.
[1] Bates, D., Levine, D., Salmasian, H., Syrowatka, A., Shahian, D., Lipsitz, S., Zebrowski, J., et al. (2023). The Safety of Inpatient Health Care. New England Journal of Medicine, 388(2), 142-153. https://doi.org/10.1056/NEJMsa2206117
The BEPI Dispenser campaign is being conducted through a capital increase involving both BEPI Dispenser S.r.l. (the "Target" company) and a newly formed vehicle called BEPI Crowd S.r.l. [SPV] (the "Vehicle" or "SPV" company ). More information in the round section.
On the BEPI Dispenser campaign, the optional Rubrication service is available for individuals for a fee.
On BEPI Dispenser, the 30% tax break applies.
BEPI Disp enser reserves the right of "liquidation preference" for all investors who join the campaign. Investors will therefore be reimbursed first in the event of exit than the company's other shareholders (according to the order of preference stated in the bylaws). All conditions are published in the bylaws found in the Documents section.
This is a marketing communication. Equity crowdfunding investments are high-risk and could result in total or partial loss of invested capital. Please read the sheet containing key investment information before joining.
BEPI Dispenser
Medical Devices
Total funding
322.117 €
Goal min 200k €
Goal max 800k €
30 investors
161% Goal min
Min order
500,00 €
Pre-Money
6,30Mln €
Warnings pursuant to art. 19 para. 2
the crowdfunding services provided by Mamacrowd do not fall under the deposit guarantee scheme established in accordance with Directive 2014/49/EU; the securities and instruments eligible for crowdfunding that can be acquired through this crowdfunding platform do not fall under the investor compensation scheme established in accordance with Directive 97/9/EC.
© 2025 Mamacrowd Srl a company of Azimut Group - VAT number IT07464370969 - Via Timavo 34, 20124 MI - SC € 95.417,54 fully paid up - Crowdfunding service provider authorised by resolution No. 22876 of 08/11/2023
Italiano
English
Italiano
English
Let us get to know you better
Mamacrowd and partners operate globally and can, upon acquiring your consent through the "Accept all", "Accept only necessary" or "Set preferences" commands, use cookies for statistical, advertising and also profiling purposes, own or third-party, to modulate the provision of the service in a personalized way and in line with your preferences.
In case of refusal we will only use the necessary cookies. For more information, read our Cookies Policy